Giampiero Mazza - Recordati Industria Ex Director
| RCDTFDelisted Stock | USD 52.25 0.00 0.00% |
Insider
Giampiero Mazza is Ex Director of Recordati Industria Chimica
| Age | 54 |
| Phone | 39 02 487871 |
| Web | https://www.recordati.com |
Recordati Industria Management Efficiency
The company has return on total asset (ROA) of 0.0937 % which means that it generated a profit of $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2167 %, meaning that it generated $0.2167 on every $100 dollars invested by stockholders. Recordati Industria's management efficiency ratios could be used to measure how well Recordati Industria manages its routine affairs as well as how well it operates its assets and liabilities.Recordati Industria Chimica has accumulated 1.84 B in total debt with debt to equity ratio (D/E) of 1.23, which is about average as compared to similar companies. Recordati Industria has a current ratio of 1.45, which is within standard range for the sector. Debt can assist Recordati Industria until it has trouble settling it off, either with new capital or with free cash flow. So, Recordati Industria's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Recordati Industria sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Recordati to invest in growth at high rates of return. When we think about Recordati Industria's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Diogo Rau | Eli Lilly and | 49 | |
| Vanessa Broadhurst | Johnson Johnson | 52 | |
| Michelle Weese | Bristol Myers Squibb | 50 | |
| Michael Fleming | Merck Company | 61 | |
| Nadim Ahmed | Bristol Myers Squibb | 51 | |
| William Hait | Johnson Johnson | 71 | |
| Azita Gerhardt | AbbVie Inc | 57 | |
| Jannie Oosthuizen | Merck Company | 53 | |
| DVM DVM | Pfizer Inc | 60 | |
| David Denton | Pfizer Inc | 59 | |
| Thomas Hudson | AbbVie Inc | 62 | |
| Martin MIBS | Eli Lilly and | 61 | |
| D Davis | Johnson Johnson | 69 | |
| Linda Louie | Amgen Inc | N/A | |
| Lisa LeCointeCephas | Merck Company | 42 | |
| William Carapezzi | Pfizer Inc | 63 | |
| Carrie Strom | AbbVie Inc | 43 | |
| Natacha Gassenbach | Biogen Inc | N/A | |
| Nadja West | Johnson Johnson | 60 | |
| Jitendra Tyagi | Bristol Myers Squibb | N/A | |
| Deepak Khanna | Merck Company | N/A | |
Management Performance
| Return On Equity | 0.22 | |||
| Return On Asset | 0.0937 |
Recordati Industria Leadership Team
Elected by the shareholders, the Recordati Industria's board of directors comprises two types of representatives: Recordati Industria inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Recordati. The board's role is to monitor Recordati Industria's management team and ensure that shareholders' interests are well served. Recordati Industria's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Recordati Industria's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Giampiero Mazza, Ex Director | ||
| Robert MD, CEO Director | ||
| Federica Medici, Director Communications | ||
| Gabriele Finzi, Vice President and Director Corporate Development | ||
| Luigi Corte, Group Director | ||
| Giuseppe Gualazzini, Vice President and Director Group Human Resources | ||
| Daria Ghidoni, Vice President and Director Corporate Legal Affairs | ||
| Cathrin Petty, Ex Director | ||
| Giovanni Minora, Head of Group Auditing, Internal Control Officer | ||
| Giorgio Palma, Ex Director |
Recordati Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Recordati Industria a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.0937 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 10.45 B | |||
| Shares Outstanding | 205.46 M | |||
| Shares Owned By Insiders | 51.80 % | |||
| Shares Owned By Institutions | 26.08 % | |||
| Price To Earning | 18.62 X | |||
| Price To Book | 4.89 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Recordati Pink Sheet
If you are still planning to invest in Recordati Industria check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Recordati Industria's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |